Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The effects of fluoride on bone.

H E Gruber1, D J Baylink

  • 1Skeletal Dysplasia Morphology Lab, Cedars-Sinai Medical Center, Los Angeles, California 90048.

Clinical Orthopaedics and Related Research
|June 1, 1991
PubMed
Summary

Fluoride treatment for osteoporosis shows mixed results. Recent data challenges its effectiveness and raises concerns about fracture risk, making it not generally recommended for postmenopausal osteoporosis currently.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Local administration of AAV-DJ pseudoserotype expressing COX2 provided early onset of transgene expression and promoted bone fracture healing in mice.

Gene therapy·2015
Same author

Genetic regulation of femoral bone mineral density: complexity of sex effect in chromosome 1 revealed by congenic sublines of mice.

Bone·2007
Same author

Detecting novel bone density and bone size quantitative trait loci using a cross of MRL/MpJ and CAST/EiJ inbred mice.

Calcified tissue international·2007
Same author

Disruption of four-and-a-half LIM 2 decreases bone mineral content and bone mineral density in femur and tibia bones of female mice.

Calcified tissue international·2006
Same author

High osteoblastic activity in C3H/HeJ mice compared to C57BL/6J mice is associated with low apoptosis in C3H/HeJ osteoblasts.

Calcified tissue international·2006
Same author

Serum levels of insulin-like growth factor (IGF); IGF-binding proteins-3, -4, and -5; and their relationships to bone mineral density and the risk of vertebral fractures in postmenopausal women.

Calcified tissue international·2006

Area of Science:

  • Endocrinology
  • Geriatrics
  • Pharmacology

Background:

  • Osteoporosis is a significant metabolic bone disease in the elderly.
  • Fluoride has historically been a treatment option for osteoporosis.
  • Monitoring patient response to fluoride therapy is crucial.

Purpose of the Study:

  • To review current fluoride monitoring techniques for osteoporosis.
  • To examine new findings on fluoride's mechanism of action, toxicity, and clinical efficacy.
  • To assess the role of dosage, administration, and side effects in fluoride treatment protocols.

Main Methods:

  • Literature review of recent clinical trial data.
  • Analysis of studies on fluoride's interaction with osteoblasts.
  • Evaluation of toxicity and carcinogenesis data related to fluoride.

Main Results:

  • New insights into fluoride's interaction with osteoblasts via growth factors.
  • Concerns regarding fluoride's toxicity and carcinogenic potential.
  • Recent clinical data question the efficacy of fluoride for postmenopausal osteoporosis, particularly regarding fracture incidence.

Conclusions:

  • Fluoride's effectiveness in treating postmenopausal osteoporosis is challenged by recent studies.
  • The implications for fracture incidence necessitate caution.
  • Fluoride is not currently recommended for general use in osteoporosis treatment.

Related Experiment Videos